Wound Biologics Market Research Report by Product, Wound Type, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Wound Biologics Market Research Report by Product, Wound Type, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

The United States Wound Biologics Market size was estimated at USD 799.26 million in 2021 and expected to reach USD 857.13 million in 2022, and is projected to grow at a CAGR 8.86% to reach USD 1,330.69 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Wound Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products.

Based on Wound Type, the market was studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers.

Based on End-User, the market was studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Wound Biologics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wound Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Wound Biologics Market, including 3M Company, Anika Therapeutics, Inc, Avita Medical, Inc., Bioventus Inc., ConvaTec Group PLC, Cytori Therapeutics Inc., Integra Lifesciences Holdings Corporation, Kerecis hf, Marine Polymer Technologies, Inc., MIMEDX GROUP, INC., Mölnlycke Health Care AB, Nuo Therapeutics, Inc., Organogenesis Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stability Biologics, Stryker Corporation, Tides Medical, Vericel Corporation, and Viatris Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Wound Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Wound Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Wound Biologics Market?
4. What is the competitive strategic window for opportunities in the United States Wound Biologics Market?
5. What are the technology trends and regulatory frameworks in the United States Wound Biologics Market?
6. What is the market share of the leading vendors in the United States Wound Biologics Market?
7. What modes and strategic moves are considered suitable for entering the United States Wound Biologics Market?

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of burn injuries, road accidents, and diabetes
5.1.1.2. Increasing wound management programs by the United States government
5.1.2. Restraints
5.1.2.1. High expenses associated with wound care treatment
5.1.3. Opportunities
5.1.3.1. Ongoing private and government initiatives for biologics research
5.1.3.2. Introduction of new products and improving reimbursement scenario
5.1.4. Challenges
5.1.4.1. Risk of bacterial contamination and biofilm formation
5.2. Cumulative Impact of COVID-19
6. Wound Biologics Market, by Product
6.1. Introduction
6.2. Biologic Skin Substitutes
6.3.1. Acellular Animal-derived Products
6.3.2. Biosynthetic Products
6.3.3. Human Donor Tissue-derived Products
6.3. Topical Agents
7. Wound Biologics Market, by Wound Type
7.1. Introduction
7.2. Burns
7.3. Surgical and Traumatic Wounds
7.4. Ulcers
7.5.1. Diabetic Foot Ulcers
7.5.2. Pressure Ulcers
7.5.3. Venous Ulcers
8. Wound Biologics Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Burn Centers
8.4. Hospitals
8.5. Wound Clinics
9. California Wound Biologics Market
9.1. Introduction
10. Florida Wound Biologics Market
10.1. Introduction
11. Illinois Wound Biologics Market
11.1. Introduction
12. New York Wound Biologics Market
12.1. Introduction
13. Ohio Wound Biologics Market
13.1. Introduction
14. Pennsylvania Wound Biologics Market
14.1. Introduction
15. Texas Wound Biologics Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. 3M Company
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Anika Therapeutics, Inc
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. Avita Medical, Inc.
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Bioventus Inc.
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. ConvaTec Group PLC
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Cytori Therapeutics Inc.
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Integra Lifesciences Holdings Corporation
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. Kerecis hf
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. Marine Polymer Technologies, Inc.
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. MIMEDX GROUP, INC.
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Mölnlycke Health Care AB
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Nuo Therapeutics, Inc.
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Organogenesis Inc.
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Skye Biologics Holdings, LLC
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Smith & Nephew PLC
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. Stability Biologics
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. Stryker Corporation
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
17.18. Tides Medical
17.18.1. Business Overview
17.18.2. Key Executives
17.18.3. Product & Services
17.19. Vericel Corporation
17.19.1. Business Overview
17.19.2. Key Executives
17.19.3. Product & Services
17.20. Viatris Inc.
17.20.1. Business Overview
17.20.2. Key Executives
17.20.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES WOUND BIOLOGICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES WOUND BIOLOGICS MARKET DYNAMICS
FIGURE 8. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 11. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2021 VS 2027 (%)
FIGURE 17. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY WOUND TYPE, 2027
FIGURE 19. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 26. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 28. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, 2018-2027 (USD MILLION)
FIGURE 30. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, 2018-2027 (USD MILLION)
FIGURE 32. CALIFORNIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. FLORIDA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. ILLINOIS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. NEW YORK WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. OHIO WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. PENNSYLVANIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. TEXAS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 40. UNITED STATES WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 41. UNITED STATES WOUND BIOLOGICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES WOUND BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2021
TABLE 3. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 38. CALIFORNIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. CALIFORNIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 40. CALIFORNIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 41. CALIFORNIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 42. FLORIDA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. FLORIDA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 44. FLORIDA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 45. FLORIDA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 46. ILLINOIS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. ILLINOIS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 48. ILLINOIS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 49. ILLINOIS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 50. NEW YORK WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. NEW YORK WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 52. NEW YORK WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 53. NEW YORK WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 54. OHIO WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. OHIO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 56. OHIO WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 57. OHIO WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 58. PENNSYLVANIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 59. PENNSYLVANIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 60. PENNSYLVANIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 61. PENNSYLVANIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 62. TEXAS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. TEXAS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 64. TEXAS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 65. TEXAS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 66. UNITED STATES WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 67. UNITED STATES WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 68. UNITED STATES WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 69. UNITED STATES WOUND BIOLOGICS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 70. UNITED STATES WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 71. UNITED STATES WOUND BIOLOGICS MARKET MERGER & ACQUISITION
TABLE 72. UNITED STATES WOUND BIOLOGICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 73. UNITED STATES WOUND BIOLOGICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 74. UNITED STATES WOUND BIOLOGICS MARKET INVESTMENT & FUNDING
TABLE 75. UNITED STATES WOUND BIOLOGICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 76. UNITED STATES WOUND BIOLOGICS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings